Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $1.47 Million - $1.93 Million
26,100 New
26,100 $1.8 Million
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $2.71 Million - $3.72 Million
-30,000 Reduced 40.54%
44,000 $4.2 Million
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $4.12 Million - $6.13 Million
44,000 Added 146.67%
74,000 $9.2 Million
Q1 2021

May 12, 2021

SELL
$116.57 - $155.01 $1.17 Million - $1.55 Million
-10,000 Reduced 25.0%
30,000 $3.95 Million
Q1 2020

May 01, 2020

BUY
$37.9 - $104.44 $189,500 - $522,200
5,000 Added 14.29%
40,000 $2.32 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $2.72 Million - $3.49 Million
35,000 New
35,000 $3.24 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.